ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 337

$509K Total Retail Price of All Prescriptions

Rank: 73 out of 337

417 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,637 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 478 390 1 2
METOPROLOL TARTRATE 442 407 2 6
LEVOTHYROXINE SODIUM 435 348 3 5
AMLODIPINE BESYLATE 417 354 4 3
HYDROCHLOROTHIAZIDE 397 361 5 9
OMEPRAZOLE 365 317 6 4
WARFARIN SODIUM 356 301 7 11
LOVASTATIN 356 330 7 24
SIMVASTATIN 318 297 9 1
FUROSEMIDE 307 242 10 8
ZOLPIDEM TARTRATE 261 220 11 23
ATENOLOL 231 203 12 10
CITALOPRAM HBR 200 177 13 17
ALENDRONATE SODIUM 191 169 14 19
METFORMIN HCL 182 169 15 12
ATORVASTATIN CALCIUM 171 140 16 7
DONEPEZIL HCL 168 158 17 22
SERTRALINE HCL 142 109 18 18
TRAZODONE HCL 141 136 19 16
HYDROCODONE-ACETAMINOPHEN 140 124 S3 20 13
PRAVASTATIN SODIUM 134 90 21 14
PANTOPRAZOLE SODIUM 134 81 21 36
PROAIR HFA 112 43 23 38
CRESTOR 111 55 24 29
MIRTAZAPINE 101 101 25 27
NAMENDA 86 72 26 35
GABAPENTIN 83 56 27 20
PAROXETINE HCL 82 73 28 46
TRAMADOL HCL 80 47 29 32
OXYCODONE HCL 80 49 S2 29 63
MORPHINE SULFATE ER 78 13 S2 31 255
ALLOPURINOL 78 66 31 28
LOSARTAN POTASSIUM 76 76 33 15
OXYCODONE-ACETAMINOPHEN 76 56 S2 33 84
QUINAPRIL HCL 75 75 35 50
FLUCONAZOLE 74 48 36 289
DIOVAN 71 64 37 26
CARVEDILOL 65 65 38 73
EXELON 61 61 39 85
AZITHROMYCIN 60 44 40 51
CLOPIDOGREL 60 43 40 42
METOPROLOL SUCCINATE 59 59 42 21
RISPERIDONE 58 58 43 72
NEXIUM 58 46 43 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 40 45 31
NITROGLYCERIN PATCH 57 44 45 215
GLYBURIDE 56 56 R 47 53
TAMSULOSIN HCL 56 53 47 25
PREDNISONE 56 36 47 40
FLUOXETINE HCL 53 53 50 57
VERAPAMIL ER 53 52 50 77
SPIRONOLACTONE 53 49 50 100
CLONIDINE HCL 52 32 53 135
SPIRIVA 51 36 54 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.